Latest Insider Transactions at Aerovate Therapeutics, Inc. (AVTE)
This section provides a real-time view of insider transactions for Aerovate Therapeutics, Inc. (AVTE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aerovate Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aerovate Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
3,433
+38.9%
|
$6,866
$2.14 P/Share
|
|
Mar 08
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
114
-5.5%
|
$2,850
$25.0 P/Share
|
|
Mar 08
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+5.21%
|
$228
$2.14 P/Share
|
|
Mar 07
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,975
-73.41%
|
$215,400
$24.5 P/Share
|
|
Mar 07
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,975
+42.33%
|
$17,950
$2.14 P/Share
|
|
Mar 07
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
22,386
-91.95%
|
$559,650
$25.0 P/Share
|
|
Mar 07
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
22,386
+47.9%
|
$44,772
$2.14 P/Share
|
|
Feb 23
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
511
-13.58%
|
$9,709
$19.5 P/Share
|
|
Feb 23
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
511
+11.96%
|
$511
$1.74 P/Share
|
|
Feb 20
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,489
-30.04%
|
$69,780
$20.35 P/Share
|
|
Feb 20
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,489
+34.11%
|
$3,489
$1.74 P/Share
|
|
Feb 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-74.09%
|
$78,200
$17.45 P/Share
|
|
Feb 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+32.88%
|
$4,600
$1.94 P/Share
|
|
Jan 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-55.16%
|
$76,000
$19.5 P/Share
|
|
Jan 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+35.55%
|
$4,000
$1.74 P/Share
|
|
Jan 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-47.42%
|
$87,400
$19.12 P/Share
|
|
Jan 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+32.88%
|
$4,600
$1.94 P/Share
|
|
Dec 27
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
125
-3.7%
|
$3,000
$24.5 P/Share
|
|
Dec 27
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
125
+3.57%
|
$250
$2.14 P/Share
|
|
Dec 20
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-55.16%
|
$76,000
$19.5 P/Share
|
|
Dec 14
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,897
-75.27%
|
$188,043
$19.5 P/Share
|
|
Dec 14
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,897
+42.95%
|
$9,897
$1.74 P/Share
|
|
Dec 13
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,103
+31.88%
|
$6,103
$1.74 P/Share
|
|
Dec 13
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,103
-39.28%
|
$39,957
$19.5 P/Share
|
|
Dec 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-88.85%
|
$164,528
$16.11 P/Share
|
|
Dec 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+39.96%
|
$10,283
$1.94 P/Share
|
|
Dec 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-74.09%
|
$73,600
$16.3 P/Share
|
|
Dec 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+32.88%
|
$4,600
$1.94 P/Share
|
|
Nov 27
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
12,517
-90.65%
|
$200,272
$16.24 P/Share
|
|
Nov 27
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
12,517
+40.85%
|
$12,517
$1.94 P/Share
|
|
Nov 24
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
4,990
-41.74%
|
$74,850
$15.91 P/Share
|
|
Nov 24
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
4,990
+44.27%
|
$9,980
$2.14 P/Share
|
|
Nov 22
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
13,800
-89.56%
|
$207,000
$15.0 P/Share
|
|
Nov 22
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+40.17%
|
$13,800
$1.94 P/Share
|
|
Nov 22
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
9,382
-87.9%
|
$140,730
$15.17 P/Share
|
|
Nov 22
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
9,382
+39.47%
|
$9,382
$1.94 P/Share
|
|
Nov 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,092
-100.0%
|
$10,920
$10.42 P/Share
|
|
Nov 01
2023
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
970
-100.0%
|
$9,700
$10.46 P/Share
|
|
Sep 07
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
30
-2.27%
|
$450
$15.01 P/Share
|
|
Sep 07
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
30
+2.22%
|
$60
$2.14 P/Share
|
|
Sep 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,931
-75.28%
|
$58,965
$15.06 P/Share
|
|
Sep 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,931
+30.98%
|
$3,931
$1.94 P/Share
|
|
Aug 07
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-56.85%
|
$154,245
$15.87 P/Share
|
|
Aug 07
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+39.96%
|
$10,283
$1.94 P/Share
|
|
Jul 28
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,478
-100.0%
|
$98,604
$18.0 P/Share
|
|
Jul 28
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,478
+50.0%
|
$10,956
$2.14 P/Share
|
|
Jul 17
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,522
-100.0%
|
$81,396
$18.11 P/Share
|
|
Jul 17
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,522
+50.0%
|
$9,044
$2.14 P/Share
|
|
Jul 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-88.85%
|
$164,528
$16.66 P/Share
|
|
Jul 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+39.96%
|
$10,283
$1.94 P/Share
|